Considering that the recNcPDI was associated with the nanogels by electrostatic interaction between the negatively charged recNcPDI and

positively charged chitosan during nanogel formation (50), it is unlikely that the recNcPDI was modified as would have occurred by conjugation process. It may be that a limited proteolysis was responsible for this effect. However, it should be noted that check details this altered size of the antigen was found in nanogels, which had been ultracentrifuged, and this may well have given rise to an artefact. Indeed, the antigen associated with mannosylated chitosan/alginate nanogels was not altered, wherein the association of the antigen with the nanogels was performed in an identical fashion. This would suggest that antigen in the chitosan/alginate particles was more susceptible to modification than that in the mannosylated chitosan/alginate nanogels. Our results confirmed that i.p. vaccination with recNcPDI antigen emulsified in saponin did not confer any protection. In contrast, association of the antigen with the nanogels was advantageous in terms of vaccine efficacy. Mice receiving Alpelisib in vivo recNcPDI associated

with either of the two types of nanogel formulations exhibited increased survival rates (60–80%). Interestingly, this was also observed with the nanogels, which were not carrying the antigen. These results were confirmed by assessment of cerebral parasite burden, although animals receiving recNcPDI-containing nanogels exhibited a lower, albeit not statistically significant, cerebral infection intensity compared to animals receiving nanogels without antigen. Thus, incorporation of recNcPDI into chitosan-based nanogels could potentially lead to improved vaccine efficacy, including reduction in cerebral invasion by N. caninum tachyzoites. Cediranib (AZD2171) How the nanogels without antigen were contributing to this phenomenon is unclear at this stage, but it may relate to a stronger innate response.

As far as the adaptive immunity is concerned, it was considered likely that this would have required the antigen. Indeed, intraperitoneal vaccination of mice with nanogels lacking a recNcPDI-antigen load did not promote any significant IgG, IgG1 and IgG2a responses against recNcPDI or crude N. caninum antigen. Therefore, the nanogels and recNcPDI do not share common epitopes or mimeotopes. In contrast, substantial antibody responses against the recNcPDI antigen, but not crude N. caninum antigen, were found in mice vaccinated with recNcPDI associated with nanogels. However, the nanogels did not appear to enhance this humoral response, neither in terms of IgG analysis nor for IgG1/IgG2a analysis. It therefore seems likely that with intraperitoneal vaccination, the nanogels would be offering an added value leading to elevated levels of protection in terms of their influence on innate immune activity. This possible importance of innate defences against N.